Literature DB >> 28571659

Gut Microbiota, Endocrine-Disrupting Chemicals, and the Diabetes Epidemic.

Ganesan Velmurugan1, Tharmarajan Ramprasath2, Mithieux Gilles3, Krishnan Swaminathan4, Subbiah Ramasamy5.   

Abstract

Diabetes is rapidly emerging as one of the biggest health concerns worldwide, with profound implications for disability, mortality, and costs. This suddenly escalating rate of diabetes correlates with global industrialization and the production of plastics, pesticides, synthetic fertilizers, electronic waste, and food additives that release endocrine-disrupting chemicals (EDCs) into the environment and the food chain. Emerging evidence indicates an association between exposure of EDCs and diabetes. In humans, these chemicals are also metabolized by the gut microbiota and thereby their toxicodynamics are altered. In this review we highlight studies that focus on the role of gut microbiota in EDC-induced hyperglycemia and dysregulated glucose homeostasis. We also discuss the translational implications of understanding EDC-microbiota interactions for the diagnosis and treatment of diabetes.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  diabetes epidemic; endocrine-disrupting chemicals; glucose homeostasis; gut microbiota; microbial dysbiosis; microbial metabolism

Mesh:

Substances:

Year:  2017        PMID: 28571659     DOI: 10.1016/j.tem.2017.05.001

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  36 in total

1.  Gut microbiota in toxicological risk assessment of drugs and chemicals: The need of hour.

Authors:  Ganesan Velmurugan
Journal:  Gut Microbes       Date:  2018-04-19

Review 2.  Immune System: An Emerging Player in Mediating Effects of Endocrine Disruptors on Metabolic Health.

Authors:  Amita Bansal; Jorge Henao-Mejia; Rebecca A Simmons
Journal:  Endocrinology       Date:  2018-01-01       Impact factor: 4.736

3.  Association of co-accumulation of arsenic and organophosphate insecticides with diabetes and atherosclerosis in a rural agricultural community: KMCH-NNCD-I study.

Authors:  Ganesan Velmurugan; Krishnan Swaminathan; Sundaresan Mohanraj; Mani Dhivakar; Ganesh Veerasekar; Thomas Alexander; Mathew Cherian; Nalla G Palaniswami; Thalappil Pradeep
Journal:  Acta Diabetol       Date:  2020-04-20       Impact factor: 4.280

Review 4.  Endocrine disruptors and gut microbiome interactions.

Authors:  R Hampl; L Stárka
Journal:  Physiol Res       Date:  2020-09-30       Impact factor: 1.881

Review 5.  Diabetes mellitus: Plasticizers and nanomaterials acting as endocrine-disrupting chemicals (Review).

Authors:  Mihaela Jana Tuculina; Paula Perlea; Mircea Gheorghiță; Cristian Niky Cumpătă; Ionela Teodora Dascălu; Adina Turcu; Andreea Gabriela Nicola; Lelia Mihaela Gheorghiță; Oana Andreea Diaconu; Ana Valea; Adina Ghemigian; Mara Carsote
Journal:  Exp Ther Med       Date:  2022-02-16       Impact factor: 2.447

Review 6.  Sequence meets function-microbiota and cardiovascular disease.

Authors:  Myungsuk Kim; Md Nazmul Huda; Brian J Bennett
Journal:  Cardiovasc Res       Date:  2022-01-29       Impact factor: 10.787

Review 7.  Gut microbiota-derived metabolites in the regulation of host immune responses and immune-related inflammatory diseases.

Authors:  Wenjing Yang; Yingzi Cong
Journal:  Cell Mol Immunol       Date:  2021-03-11       Impact factor: 11.530

Review 8.  Opportunities and Challenges for Gut Microbiota in Acute Leukemia.

Authors:  Tao Ma; Yan Chen; Li-Juan Li; Lian-Sheng Zhang
Journal:  Front Oncol       Date:  2021-07-07       Impact factor: 6.244

9.  How does the early life environment influence the oral microbiome and determine oral health outcomes in childhood?

Authors:  Christina Jane Adler; Kim-Anh Lê Cao; Toby Hughes; Piyush Kumar; Christine Austin
Journal:  Bioessays       Date:  2021-06-20       Impact factor: 4.653

Review 10.  Praegnatio Perturbatio-Impact of Endocrine-Disrupting Chemicals.

Authors:  Vasantha Padmanabhan; Wenhui Song; Muraly Puttabyatappa
Journal:  Endocr Rev       Date:  2021-05-25       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.